Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 7 studies | 22% ± 5% | |
glutamatergic neuron | 5 studies | 41% ± 21% | |
epithelial cell | 5 studies | 27% ± 7% | |
oligodendrocyte | 5 studies | 19% ± 2% | |
neuron | 4 studies | 23% ± 6% | |
astrocyte | 4 studies | 28% ± 3% | |
hepatocyte | 3 studies | 32% ± 15% | |
GABAergic neuron | 3 studies | 46% ± 14% | |
oligodendrocyte precursor cell | 3 studies | 27% ± 2% | |
interneuron | 3 studies | 35% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5654.73 | 1445 / 1445 | 100% | 52.37 | 183 / 183 |
liver | 100% | 6452.06 | 226 / 226 | 100% | 55.33 | 406 / 406 |
pancreas | 100% | 3458.56 | 328 / 328 | 100% | 46.88 | 178 / 178 |
prostate | 100% | 5779.69 | 245 / 245 | 100% | 62.94 | 502 / 502 |
stomach | 100% | 4748.98 | 359 / 359 | 100% | 61.73 | 286 / 286 |
thymus | 100% | 6294.70 | 653 / 653 | 100% | 60.28 | 605 / 605 |
breast | 100% | 5352.66 | 459 / 459 | 100% | 52.20 | 1117 / 1118 |
skin | 100% | 7406.86 | 1809 / 1809 | 100% | 68.76 | 471 / 472 |
uterus | 100% | 6487.72 | 170 / 170 | 100% | 54.71 | 458 / 459 |
ovary | 100% | 6648.69 | 180 / 180 | 100% | 61.46 | 429 / 430 |
brain | 100% | 4775.67 | 2634 / 2642 | 100% | 70.18 | 705 / 705 |
adrenal gland | 100% | 20780.41 | 258 / 258 | 100% | 69.32 | 229 / 230 |
intestine | 100% | 6242.66 | 966 / 966 | 99% | 63.59 | 524 / 527 |
kidney | 100% | 5171.29 | 89 / 89 | 99% | 35.78 | 895 / 901 |
lung | 100% | 4660.19 | 577 / 578 | 99% | 42.29 | 1148 / 1155 |
bladder | 100% | 6361.33 | 21 / 21 | 99% | 77.66 | 500 / 504 |
adipose | 100% | 4601.58 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 48.50 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 42.49 | 29 / 29 |
spleen | 100% | 6724.44 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 47.06 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 63.66 | 1 / 1 |
blood vessel | 100% | 4706.64 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 3285.37 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 3136.03 | 850 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 3950.62 | 882 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045541 | Biological process | negative regulation of cholesterol biosynthetic process |
GO_0008203 | Biological process | cholesterol metabolic process |
GO_0032868 | Biological process | response to insulin |
GO_0033552 | Biological process | response to vitamin B3 |
GO_0042304 | Biological process | regulation of fatty acid biosynthetic process |
GO_0044255 | Biological process | cellular lipid metabolic process |
GO_0006955 | Biological process | immune response |
GO_0032933 | Biological process | SREBP signaling pathway |
GO_0001666 | Biological process | response to hypoxia |
GO_0045540 | Biological process | regulation of cholesterol biosynthetic process |
GO_0045542 | Biological process | positive regulation of cholesterol biosynthetic process |
GO_0090110 | Biological process | COPII-coated vesicle cargo loading |
GO_0032936 | Cellular component | SREBP-SCAP complex |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0012507 | Cellular component | ER to Golgi transport vesicle membrane |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0051082 | Molecular function | unfolded protein binding |
GO_0032934 | Molecular function | sterol binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SCAP |
Protein name | SREBF chaperone Sterol regulatory element-binding protein cleavage-activating protein (SCAP) (SREBP cleavage-activating protein) SCAP protein |
Synonyms | PSEC0227 KIAA0199 |
Description | FUNCTION: Escort protein required for cholesterol as well as lipid homeostasis (By similarity). Regulates export of the SCAP-SREBP complex from the endoplasmic reticulum to the Golgi upon low cholesterol, thereby regulating the processing of sterol regulatory element-binding proteins (SREBPs) SREBF1/SREBP1 and SREBF2/SREBP2 (By similarity). At high sterol concentrations, formation of a ternary complex with INSIG (INSIG1 or INSIG2) leads to mask the ER export signal in SCAP, promoting retention of the complex in the endoplasmic reticulum (By similarity). Low sterol concentrations trigger release of INSIG, a conformational change in the SSD domain of SCAP, unmasking of the ER export signal, promoting recruitment into COPII-coated vesicles and transport of the SCAP-SREBP to the Golgi: in the Golgi, SREBPs are then processed, releasing the transcription factor fragment of SREBPs from the membrane, its import into the nucleus and up-regulation of LDLR, INSIG1 and the mevalonate pathway (By similarity). Binds cholesterol via its SSD domain (By similarity). . |
Accessions | C9JFY0 C9JQ35 F8W921 ENST00000495603.2 D6RA39 F8W9W7 ENST00000441517.6 F8WDP3 Q6PIX8 ENST00000265565.10 [Q12770-1] ENST00000416208.5 ENST00000320017.10 ENST00000648151.1 [Q12770-1] Q12770 ENST00000416847.5 ENST00000448217.2 |